Archive for the 'russia' tag

Lundbeck launches alcohol dependence drug Selincro in heavy-drinking countries

Danish drugmaker Lundbeck has been suffering a...
Read more

Russia tells Abbott no-go on buyout of partner Petrovax

Russia is one of the emerging BRIC countries that...
Read more

Japan’s Eisai plans major rollout in coveted Russian market

Russia is a coveted, if challenging, market for...
Read more

Russia sets out limits to purchasing imported meds

Russia is tightening the screws on foreign...
Read more

Cancer sales boost Russia’s Pharmstandard by 84%

Leading Russian drugmaker Pharmstandard saw third...
Read more

Willing Russians help Big Pharma move into market there

As Russia tries to build its drugmaking...
Read more

Are emerging markets worth $47B less than pharma expected?

Emerging news about emerging markets has dampened...
Read more

The world’s 11 fastest-growing generics makers gain from branded pain

For generics makers, Big Pharma 's patent...
Read more

Foreign demand saves Ipsen’s primary-care plant

Ipsen 's news isn't all bad these days....
Read more

Is Stada looking at another Russian M&A prospect?

Does Stada CEO Hartmut Retzlaff know something we...
Read more

Another day, another deal for Valeant’s Pearson

Valeant Pharmaceuticals ( $VRX ) made the...
Read more

S. Africa ratchets up protection for domestic drugmakers

Warning to pharma companies aiming to sell key...
Read more

Valeant nabs Russia’s Natur Produkt for $175M-plus

We sound like a broken record when it comes to...
Read more

Stada stymied in bids for Russian M&A

Germany's Stada wants to expand in Russia....
Read more

Teva’s Viagra copy to stay on Russian market

Teva Pharmaceutical Industries may have failed at...
Read more

Ipsen weighs strategies for Russian growth

France’s Ipsen hung out a shingle in Russia...
Read more

Bayer inks pledge to J.V. with Russia’s Yunona

Bayer is the latest drugmaker to team up with a...
Read more

Germany’s Stada amenable to merger of equals

Germany’s Stada has been casting about for...
Read more

Dr. Reddy’s eyes acquisitions in Russia

India’s Dr. Reddy’s Laboratories...
Read more

Takeda eyes Indian M&A, but Cipla, Lupin deny talks

Takeda Pharmaceutical is shopping in India, but...
Read more

Merck shifts China strategy away from hiring reps

Forget Merck’s ( $MRK )?plans to recruit...
Read more

Pfizer and ChemRar to Explore Innovative Medical Research and Development Partnership in Russia

Pfizer Inc. (NYSE: PFE) and the Russian...
Read more

Pfizer and ChemRar to Explore Innovative Medical Research and Development Partnership in Russia

Pfizer Inc. (NYSE: PFE) and the Russian...
Read more

Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant in St. Petersburg, Russia

Novartis held a groundbreaking ceremony to...
Read more

Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant in St. Petersburg, Russia

Novartis held a groundbreaking ceremony to...
Read more